In order to thoroughly implement the spirit of the 20th National Congress of the Communist Party of China and the Second Plenary Session of the 20th Central Commission for Discipline Inspection, carry out centralized rectification of corruption in the pharmaceutical field, and enhance the ideological awareness of company cadres to resist corruption and prevent degeneration, on November 24th, the company organized a special work meeting on centralized rectification of corruption in the pharmaceutical field. Shen Fanshun, the secretary of the company's party branch and chairman, presided over the meeting, and members of the company's leadership team, middle-level management personnel, and representatives of the marketing center attended the meeting.

The meeting organized the study of typical cases of violations of discipline and law, medical ethics and conduct issues in the group company, and the implementation plan for the centralized rectification of corruption in the pharmaceutical field. The work deployment was also made for the centralized rectification of corruption issues in the pharmaceutical field by the company.

The meeting pointed out that conducting this centralized learning is not only to learn the spirit of the superior documents, but also to unite efforts, improve understanding, and ensure implementation. We should carefully understand the spirit of superior documents, firmly shoulder political responsibility, main responsibility, and supervision responsibility, and improve our legal and risk awareness through studying relevant laws and regulations, typical cases, and preventive measures.

The meeting requires us to elevate our political stance, establish a negative list of issues based on the identified prominent problems, strengthen the collection of problem clues, enhance our ability to identify problems, and investigate violations of discipline and law from problem to person. At the same time, all employees should actively participate in this rectification action, effectively play their role, and test the effectiveness of our work through practical actions.

The meeting emphasized that as a state-owned enterprise under Hunan Pharmaceutical Development Group, the company must always strictly abide by national laws, regulations, and industry norms, adhere to compliant operation, continuously improve the company's compliance management system, enhance employees' awareness of integrity, risk, and compliance, and create a clean and upright business environment for the company through integrity construction, providing strong support for the company's high-quality development.